This article provides an overview of Singulair (Montelukast), including its place in treatment, how it may help, and the safety issues that deserve attention. For allergy, cough, and cold relief, personal factors and the exact product matter; information for one patient or formulation may not fit another. Confirm dosing and suitability with the current label and a clinician or pharmacist before starting, stopping, or changing any medicine.
The medicine also carries the heaviest warning the FDA can place on a drug: a boxed warning for serious mental health side effects. Since 2020, the Singulair and montelukast labels have carried this boxed warning describing serious neuropsychiatric events, including agitation, depression, sleep disturbances, and, rarely, suicidal thoughts and actions. The FDA simultaneously emphasized that the drug should generally be reserved for situations in which other treatments are inadequate or cannot be tolerated.
Those two facts sit together uneasily for many families, and both belong in the same conversation.
What Is Singulair?
Singulair is a leukotriene receptor antagonist, a drug class with a single well-defined job: preventing leukotrienes from attaching to their receptors and triggering airway inflammation and constriction. Generic montelukast is widely prescribed alongside the brand, and both are prescription only.
The drug is oral, which shapes its appeal and its limits. A once-daily tablet avoids the coordination that inhalers demand, which is why it is often considered for young children, for patients who struggle with inhaler technique, or for people whose asthma and allergies travel together. But an oral anti-inflammatory pill is also systemic: it circulates everywhere, not just in the lungs, which is part of why its mental health warning applies to the whole patient rather than to one organ.
It is equally important to state what Singulair is not. It is not a rescue medicine. It does not open airways in an attack within minutes, and it cannot substitute for a fast-acting inhaler. Every patient taking montelukast still needs a rescue plan.
What Is Singulair Used For?
The FDA-approved uses cover three overlapping situations. First, it is approved for the maintenance treatment of asthma, meaning prevention and long-term control rather than emergency relief, in adults and children across a broad age range. Second, it is approved to prevent exercise-induced bronchoconstriction, the airway narrowing triggered by physical exertion in susceptible people. Third, it is approved to relieve symptoms of seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis.
In treatment guidelines, inhaled corticosteroids hold first place for persistent asthma, and montelukast is generally an add-on or an alternative chosen for specific reasons: inhaler difficulties, coexisting allergic rhinitis, exercise-triggered symptoms, or intolerance of other options. For allergic rhinitis alone, most guidelines place nasal steroid sprays and antihistamines ahead of montelukast, reserving it for patients with both nasal and asthmatic symptoms or particular circumstances.
None of these uses is a cure. They describe symptom control that lasts only as long as the medicine is taken.
How Does Singulair Work?
When allergens, viruses, cold air, or exercise provoke sensitive airways, immune cells release leukotrienes, potent inflammatory messengers. Leukotrienes make airway smooth muscle contract, swell the airway lining, and stimulate mucus production. In asthma, this cascade drives everyday symptoms and full attacks alike; in allergic rhinitis, it inflames the nasal lining.
Montelukast blocks the doorway those chemicals use. It binds to the cysteinyl leukotriene receptor, the CysLT1 receptor, on airway tissue, occupying the site so leukotrienes cannot latch on and act. The effect is preventative rather than immediate: taken daily, the drug lowers the background level of leukotriene-driven inflammation, so airways are less twitchy, night symptoms ease, and exercise triggers less narrowing. Because it intercepts a different pathway than antihistamines or steroids, it can complement both.
Available Forms and Strengths
Montelukast comes in three formats matched to age and swallowing ability. Doses are once daily, and the amount is fixed by age band rather than weight. The table below summarizes the standard forms; the prescription will specify which one applies.
| Form | Strength | Typical age group |
|---|---|---|
| Film-coated tablet | 10 mg | Adults and adolescents 15 and older |
| Chewable tablet | 5 mg | Children 6 to 14 |
| Chewable tablet or oral granules | 4 mg | Children 2 to 5 (granules approved down to 12 months for asthma) |
The granules can be poured onto a spoon of applesauce, rice, or similar soft food, or dissolved in breast milk or formula, then given promptly. They must not be mixed into liquid for later or stored once prepared.
How to Take Singulair
For asthma maintenance, the standard instruction is one dose once daily in the evening, with or without food, taken consistently. For allergic rhinitis, patients follow their prescription’s timing instructions, which may be evening or otherwise. For exercise-induced bronchoconstriction, the labeled approach is a single dose taken shortly before exercise, commonly about two hours ahead, with no more than one dose in a 24-hour period; patients who already take a daily dose for asthma do not add an extra one before workouts. These are label-shape instructions, and your prescriber’s directions always govern the exact schedule for you or your child.
Consistency is the medicine’s whole strategy. Singulair builds its protective effect from steady daily exposure, so it belongs in a routine, such as alongside the evening toothbrush, rather than in a cabinet pulled out only on bad days.
Missed Dose
If a dose is forgotten, take it when remembered, unless it is nearly time for the next scheduled dose, in which case skip the missed one and continue as usual. Do not take two doses at once to catch up.
Overdose and Emergency Help
If someone takes much more than the prescribed amount, contact Poison Control at 1-800-222-1222 in the United States or seek emergency care, even when no symptoms have appeared. An overdose can cause excessive drowsiness, thirst, nausea, vomiting, and, in children particularly, agitation and restlessness that may mask serious effects. For any child who has taken another person’s tablets, seek help immediately, because strengths are age-specific.
Common Side Effects of Singulair
Most people take montelukast without significant trouble, and its side effect profile is generally milder than many alternatives for daily control. The effects below are the ones reported most often; a table separates common from less common experiences.
| Common side effects | Less common side effects |
|---|---|
| Headache | Upper respiratory symptoms such as cough or congestion |
| Stomach pain or upset | Elevated liver enzymes on blood tests |
| Tiredness or drowsiness | Rash or itching |
| Vivid or unusual dreams | Diarrhea or nausea |
Two categories deserve special attention. Behavior and mood changes, including irritability, restlessness, and disrupted sleep, appear in the common-to-uncommon range depending on the population, and they are not harmless quirks; they overlap with the neuropsychiatric events behind the boxed warning and should always be reported. Second, dreams: many patients notice unusually vivid dreams, which alone is usually benign, but sleep disturbance combined with mood change warrants a call to the prescriber.
The Boxed Warning: Serious Side Effects and Warnings
Singulair’s boxed warning, the FDA’s most serious safety designation, concerns serious neuropsychiatric events. Reported events across the drug’s history include agitation and aggressive behavior, depression, disorientation, sleep problems and nightmares, hallucinations, stuttering, tremor, restlessness, and, in rare cases, suicidal thoughts and actions. Some events occurred in patients with no prior psychiatric history.
In 2020, the FDA reviewed years of reports and strengthened the warning, also emphasizing that montelukast should generally be reserved for allergic rhinitis patients who do not respond to or tolerate other treatments. The agency’s practical advice to families is direct: discuss the risks before starting, watch closely for mood, behavior, or sleep changes at any point during treatment, and contact the prescriber promptly if they appear. Anyone with thoughts of self-harm needs immediate help, such as calling or texting the 988 Suicide and Crisis Lifeline in the United States or going to an emergency room.
Other serious, though rare, warnings belong here too. In patients tapering oral steroids, montelukast has occasionally unmasked a rare condition called eosinophilic granulomatosis with polyangiitis, historically known as Churg-Strauss syndrome, marked by worsening asthma, eosinophil counts, rash, or nerve pain; evaluation is needed rather than another dose. Serious allergic reactions, including swelling and rare liver inflammation with eosinophilia, have also been reported. And the structural rule bears repeating: this is a controller, not a rescue medicine, so it must never be relied on to treat an acute attack; a fast-acting inhaler must be available at all times.
Who Should Use Singulair With Caution?
Montelukast interacts with few drugs and suits many patients, but certain groups and situations call for closer monitoring or a different choice.
Drug Interactions
Montelukast is metabolized by liver enzymes that some drugs induce, notably phenobarbital and rifampin, which can lower montelukast levels and blunt its effect. Beyond those, significant interactions are few. Even so, give your full medication list, including herbal products, to the prescriber and pharmacist, and mention any liver disease, since montelukast is processed hepatically and rare liver effects have been reported.
Pregnancy and Breastfeeding
Pregnancy complicates asthma care, because uncontrolled asthma poses real risks to both parent and baby, so treatment generally continues under medical supervision. Montelukast data in pregnancy are more limited than data for inhaled corticosteroids, and guidelines therefore usually favor inhalers as first choice, while montelukast remains an option when alternatives are unsuitable. Women who are pregnant, planning pregnancy, or breastfeeding should review the whole asthma and allergy plan with their clinician rather than adjusting any single medicine on their own.
Children and Older Adults
Montelukast is approved for young ages, down to 12 months for asthma maintenance with granules, which makes it a common pediatric option. The trade-off is that children cannot always articulate mood changes, so parents and caregivers should watch for irritability, aggression, sleep disturbance, nightmares, or withdrawal, and report them early. In older adults, the main considerations are other medications and liver and kidney function.
Storage and Handling
Store tablets and chewables at room temperature, dry and away from light, in their original container with the lid closed. Keep them above counter height and out of children’s reach, particularly because the chewable forms look and taste like candy. Granules deserve careful handling: they come in sealed foil packets, should not be opened until use, and any prepared mixture must be given promptly rather than saved. Check expiration dates seasonally, and take outdated medicine to a pharmacy take-back program.
How Quickly It Works and How Long It Lasts
Because montelukast prevents rather than reverses airway changes, its benefits appear on a timetable of days, not minutes. Some patients with allergic rhinitis notice improvement within the first day, while asthma control generally builds over the first week or longer of consistent dosing, with full benefit assessed over subsequent weeks. Each dose lasts about a day. When the drug is stopped, its protective effect fades, so stopping decisions belong with the prescriber. If weeks pass without meaningful improvement, that is useful information for the treatment plan, pointing toward a change rather than a higher expectation.
Alternatives and Comparisons
For persistent asthma, inhaled corticosteroids are the cornerstone, delivered straight to the airways with far less systemic exposure than an oral pill. Combination inhalers that pair a steroid with a long-acting bronchodilator, such as salmeterol or formoterol, manage moderate disease well. For patients weighing Singulair against these, the honest comparison is convenience and swallowing versus potency and safety record: montelukast wins on simplicity, loses on strength of anti-inflammatory effect, and carries the mental health warning that inhalers do not.
For allergic rhinitis, intranasal steroid sprays such as fluticasone and second-generation antihistamines such as cetirizine or loratadine are usually tried first, with montelukast reserved for combined asthma-plus-allergy cases or intolerance of the others. Within its own class, zafirlukast offers a similar mechanism but has its own practical drawbacks, so it is less commonly used. For severe asthma unresponsive to standard therapy, biologic injections targeting specific immune pathways represent the newest tier. The right arrangement depends on age, trigger profile, inhaler skill, and risk tolerance, and it should be revisited whenever control drifts or side effects appear.
Frequently Asked Questions
What is the Singulair boxed warning about?
The FDA’s boxed warning describes serious neuropsychiatric events reported with montelukast, including agitation, aggression, depression, sleep disturbances, hallucinations, and rarely suicidal thoughts or actions. Since 2020 the warning has appeared prominently on the label, along with guidance to reserve the drug for patients whose alternatives are inadequate. Families should watch mood and behavior closely throughout treatment.
Can Singulair be used to stop an asthma attack?
No. Montelukast is a preventive, long-acting controller and works far too slowly for an attack in progress. A fast-acting rescue inhaler, such as albuterol or levalbuterol, must always be available, and an attack that does not respond to the rescue inhaler is an emergency requiring urgent medical help.
Why is Singulair taken in the evening?
For asthma maintenance, evening dosing matches the drug’s protective action to overnight hours, when airway function naturally dips and symptoms often peak. Follow your prescription’s exact instructions, since exercise prevention and allergy uses may be timed differently.
What mood or behavior changes should prompt a call to the doctor?
Report irritability, aggression, restlessness, sadness, anxiety, nightmares, hallucinations, trouble sleeping, or any talk of self-harm as soon as they appear, in adults or children. Do not simply wait for the next appointment, and never dismiss new behavior as a phase while the drug continues. Sudden thoughts of self-harm require immediate crisis help, such as the 988 lifeline in the United States.
Can my child take Singulair with their allergy medicines?
Often yes, and combinations are common, since montelukast works on a different pathway than antihistamines. The specific mix should be confirmed with the pediatrician or pharmacist. Never add an over-the-counter allergy pill to a prescription without checking.
How long does it take for Singulair to start working?
Allergy symptoms may improve within a day or so, while asthma control typically builds over one to two weeks of daily dosing and is fully judged after longer use. The medicine only works while it is taken consistently. If weeks pass with no clear benefit, tell your prescriber, who may adjust the plan rather than the dose.
Is generic montelukast the same as brand Singulair?
Generic montelukast contains the same active ingredient at the same strength and is held to FDA standards for equivalence, so patients can generally expect the same effects. What matters for safety is identical too: the boxed warning applies to the molecule, not the brand.
Conclusion
Singulair occupies a useful but carefully fenced corner of asthma and allergy care. A once-daily pill that blocks leukotrienes can steady airways, quiet exercise-triggered symptoms, and ease allergic rhinitis, all without an inhaler. The same molecule, however, carries an FDA boxed warning for serious mental health side effects, and the agency has steered it toward patients whose other options fall short. That balance is the practical takeaway: montelukast is neither a villain nor a harmless tablet, but a real medicine with a real warning that rewards attentive use. Take it daily as prescribed, keep the rescue inhaler close, watch mood and sleep in every patient young or old, and stay in regular contact with the clinician who can judge whether this drug is still the right fit.
Medical Disclaimer
The discussion above is educational and especially cannot capture the individual risk-benefit judgment that montelukast requires.
Medical Disclaimer: This article is for informational and educational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Follow the official product instructions and seek urgent medical assistance for a medical emergency.
References and Sources
- DailyMed — Singulair (montelukast) product labeling — official FDA-approved label, including the boxed warning, uses, and dosing.
- MedlinePlus — Drug Information — consumer-level information on montelukast and its risks.
- FDA Drugs@FDA — federal database of approved products, including montelukast generics.
- U.S. FDA — Drugs — agency drug safety communications and guidance on montelukast’s boxed warning.